Subtype
Malignant Reproductive System Neoplasm
CI-CAN-00001172Explore in graph →
2,804 active trials38 approved drugs186 evidence items
- NCIt
- C36076
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001172Explore in graph →
Clinical trials
12,158 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,473)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06415500 | A Study on the Safety and Preliminary Efficacy of NK042 in the Treatment of Malignant Ascites | not yet recruiting | Phase 1 | 9 | Anhui Provincial HospitalOTHER_GOV | 1 | May 16, 2024 | clinicaltrials |
| NCT05921149 | Fasting Mimicking Diet (FMD) in Conjunction With Chemotherapy in Advanced Ovarian Cancer | not yet recruiting | N/A | 170 | Endeavor HealthOTHER | 1 | May 7, 2024 | clinicaltrials |
| NCT06393543 |
| International Registration of Isolated STIC: to Report and Investigate the Risk of Serous Peritoneal Carcinomatosis(STICRISC) |
| not yet recruiting |
| — |
| 600 |
| Radboud University Medical CenterOTHER |
| 0 |
| May 1, 2024 |
| clinicaltrials |
| NCT06383507 | A Clinical Study of Anti-CD70 UCAR-T in Relapsed or Refractory Solid Tumors | not yet recruiting | Phase 1 | 18 | Zhejiang UniversityOTHER | 0 | Apr 25, 2024 | clinicaltrials |
| NCT06358053 | CRTE7A2-01 TCR-T Cells for HPV-16 Positive Advanced Cancers | not yet recruiting | Phase 1 | 24 | Corregene Biotechnology Co., LtdINDUSTRY | 0 | Apr 10, 2024 | clinicaltrials |
| NCT06315270 | To Explore the Feasibility of Dynamic Changes of TCR Diversity in Peripheral Blood in Monitoring Recurrence and Evaluating Prognosis of Epithelial Ovarian Cancer | not yet recruiting | — | 100 | The First Hospital of Jilin UniversityOTHER | 0 | Apr 1, 2024 | clinicaltrials |
| NCT06333821 | A Study of Nimotuzumab Plus Concurrent Chemoradiotherapy Sequential Maintenance Treatment for Cervical Carcinoma | not yet recruiting | Phase 3 | 460 | Biotech Pharmaceutical Co., Ltd.OTHER | 0 | Mar 27, 2024 | clinicaltrials |
| NCT06329323 | SerUm and Plasma MicroRNAs in Malignant Ovarian gERm Cell Tumours(SUMMER) | not yet recruiting | — | 24 | Imperial College LondonOTHER | 0 | Mar 26, 2024 | clinicaltrials |
| NCT06297811 | Myeloprotection With Trilaciclib in Pan-cancer Population | not yet recruiting | Phase 2 | 132 | Sun Yat-sen UniversityOTHER | 1 | Mar 7, 2024 | clinicaltrials |
| NCT06271551 | Transdermal Estradiol and Exercise in Mitigating Adverse Effects of Androgen Deprivation Therapy for Prostate Cancer Radiation Therapy(ESTRACISE) | not yet recruiting | Phase 2 | 310 | Central Finland Hospital DistrictOTHER | 0 | Feb 21, 2024 | clinicaltrials |
| NCT06202339 | Alpha Radiation Emitters Device for the Treatment of Primary and Recurrent Squamous Cell Carcinoma of the Vulva (DaRT). | not yet recruiting | N/A | 10 | Alpha Tau Medical LTD.INDUSTRY | 0 | Jan 31, 2024 | clinicaltrials |
| NCT04176081 | Study of Radiation Therapy in Combination With Darolutamide + Degarelix in Intermediate Risk Prostate Cancer(SChLAP/IDC) | not yet recruiting | Phase 2 | 208 | University Health Network, TorontoOTHER | 1 | Jan 24, 2024 | clinicaltrials |
| NCT06066216 | Cadonilimab (AK104) Plus Chemotherapy in Patients With Recurrent or Advanced Endometrial Cancer | not yet recruiting | Phase 2 | 45 | Fujian Cancer HospitalOTHER_GOV | 0 | Jan 23, 2024 | clinicaltrials |
| NCT06204354 | Construction of Gynecological Tumor Sample Library | not yet recruiting | — | 2,500 | Peking Union Medical College HospitalOTHER | 0 | Jan 12, 2024 | clinicaltrials |
| NCT06197126 | MRI-based Signatures for Survival Prediction in Cervical Cancer With Radiotherapy | not yet recruiting | — | 200 | Fujian Cancer HospitalOTHER_GOV | 1 | Jan 9, 2024 | clinicaltrials |
| NCT06188455 | Maintenance Therapy After Platinum-containing Chemotherapy in Patients With Recurrent Ovarian Cancer | not yet recruiting | Phase 3 | 37 | The First Affiliated Hospital of Xiamen UniversityOTHER | 0 | Jan 3, 2024 | clinicaltrials |
| NCT05411354 | Analyzing Clinical Trial Experiences of Prostate Cancer Patients | not yet recruiting | — | 400 | Power Life Sciences Inc.INDUSTRY | 1 | Jan 2, 2024 | clinicaltrials |
| NCT04889742 | Hyperthermia Enhanced Re-irradiation of Loco-regional Recurrent Tumors(HETERERO) | not yet recruiting | Phase 2 | 110 | Charite University, Berlin, GermanyOTHER | 1 | Dec 26, 2023 | clinicaltrials |
| NCT06150222 | Retrospective Cervical Cancer Oligo States (Recurrence, Metastasis) Multicentre Outcomes Study(Retro-COSMOS) | not yet recruiting | — | 350 | Erasmus Medical CenterOTHER | 0 | Dec 1, 2023 | clinicaltrials |
| NCT06128460 | Adjuvant Chemoradiotherapy Followed by Zimberelimab for Locally Advanced Cervical Cancer. | not yet recruiting | Phase 2 | 24 | Obstetrics & Gynecology Hospital of Fudan UniversityOTHER | 0 | Nov 30, 2023 | clinicaltrials |
| NCT06149767 | Clinical Study of Adebrelimab Combined With Concurrent Chemoradiotherapy in Cervical Cancer | not yet recruiting | Phase 2 | 26 | Fujian Cancer HospitalOTHER_GOV | 0 | Nov 29, 2023 | clinicaltrials |
| NCT06145958 | Radiotherapy and Androgen Deprivation In Combination After Local Surgery (RADICALS) Translational Study(RADICALS-TR) | not yet recruiting | — | 2,585 | University College, LondonOTHER | 0 | Nov 24, 2023 | clinicaltrials |
| NCT06142500 | WEST-KOaST Study: WES Analysis of Testicular Cancer Patientsand Their First-degree Family Members(West-KOaSt) | not yet recruiting | N/A | 4,500 | IRCCS San RaffaeleOTHER | 0 | Nov 21, 2023 | clinicaltrials |
| NCT06136377 | Evaluation of the Concordance Between Pre-therapy Dosimetry Performed From 68Ga-PSMA-11 Dynamic PET and Post-treatment Dosimetry of 177Lu-PSMA-617 Vectorized Internal Radiotherapy in Patients With Metastatic Prostate Cancer Resistant to Hormonal Castration.(GaLuPro) | not yet recruiting | N/A | 35 | Centre Georges Francois LeclercOTHER | 0 | Nov 18, 2023 | clinicaltrials |
| NCT06129851 | Relugolix in Combination With Radiation Therapy for Treating Patients With High Risk Prostate Cancer | not yet recruiting | Phase 2 | 90 | University of Kansas Medical CenterOTHER | 1 | Nov 13, 2023 | clinicaltrials |
| NCT06118463 | Study on AUNIP as a Novel Tumor Marker for Cervical Cancer | not yet recruiting | — | 300 | Lin YuanOTHER | 0 | Nov 9, 2023 | clinicaltrials |
| NCT06101966 | A Predictive Model for Early Metastasis in Cervical Cancer Patients After Radiotherapy | not yet recruiting | — | 500 | Fujian Cancer HospitalOTHER_GOV | 1 | Oct 26, 2023 | clinicaltrials |
| NCT06081595 | Fluzoparib Combined With Apatinib in Relapsed Ovarian Carcinoma Maintenance Treatment | not yet recruiting | Phase 2 | 54 | Jin LiOTHER | 0 | Oct 13, 2023 | clinicaltrials |
| NCT06070272 | Determining Patterns In Trial Experiences of Recurrent Prostate Cancer Patients | not yet recruiting | — | 500 | Power Life Sciences Inc.INDUSTRY | 1 | Oct 6, 2023 | clinicaltrials |
| NCT06070285 | Investigating Participation Patterns Among Recurrent Ovarian Cancer Patients | not yet recruiting | — | 500 | Power Life Sciences Inc.INDUSTRY | 1 | Oct 6, 2023 | clinicaltrials |
| NCT06062589 | AK104 Combined With I-125 Brachytherapy for Recurrent or Metastatic Cervical Cancer | not yet recruiting | — | 18 | Peking University Third HospitalOTHER | 0 | Oct 2, 2023 | clinicaltrials |
| NCT06063070 | First-line Maintenance Treatment With Fluzoparib Plus Bevacizumab in Advanced BRCA Wild Type Ovarian Cancer | not yet recruiting | Phase 2 | 44 | Sun Yat-sen UniversityOTHER | 1 | Oct 2, 2023 | clinicaltrials |
| NCT06039982 | A Diagnostic Nomogram for Predicting Vaginal Invasion in Cervical Cancer | not yet recruiting | — | 100 | Fujian Cancer HospitalOTHER_GOV | 1 | Sep 26, 2023 | clinicaltrials |
| NCT06055114 | Study on Vaginal Microecology and Cervical Local Immune Function in Patients With Uterine Fibroids of Childbearing Age | not yet recruiting | — | 300 | Lin YuanOTHER | 0 | Sep 26, 2023 | clinicaltrials |
| NCT06039891 | Nimotuzumab Plus Tislelizumab for Recurrent and Metastatic Cervical Cancer | not yet recruiting | Phase 2 | 55 | Peking Union Medical College HospitalOTHER | 0 | Sep 15, 2023 | clinicaltrials |
| NCT06009549 | A Journey Into Participation Patterns Among Metastatic Prostate Cancer Patients | not yet recruiting | — | 500 | Power Life Sciences Inc.INDUSTRY | 1 | Aug 24, 2023 | clinicaltrials |
| NCT05998798 | Revealing Engagement Patterns Among Endometrial Cancer Patients | not yet recruiting | — | 500 | Power Life Sciences Inc.INDUSTRY | 1 | Aug 21, 2023 | clinicaltrials |
| NCT05998811 | Insights Into Participating in Studies for Uterine Cancer | not yet recruiting | — | 500 | Power Life Sciences Inc.INDUSTRY | 1 | Aug 21, 2023 | clinicaltrials |
| NCT05794659 | Adjuvant Therapeutic Cancer Vaccine (AST-201, pUMVC3-hIGFBP-2) in Patients With Advanced Ovarian Cancer(Cornerstone4) | not yet recruiting | Phase 2 | 98 | Aston Sci. Inc.INDUSTRY | 1 | Jul 20, 2023 | clinicaltrials |
| NCT05931055 | The Effectiveness of Liquid Biopsy in Differential Diagnosis and Early Screening of Epithelial Ovarian Cancer | not yet recruiting | — | 1,000 | Peking Union Medical College HospitalOTHER | 0 | Jul 5, 2023 | clinicaltrials |
| NCT05840042 | Epidemiology and Risk Factors of Uterine Fibroids in China | not yet recruiting | — | 20,000 | Shixuan WangOTHER | 0 | Jun 22, 2023 | clinicaltrials |
| NCT05799469 | Study of Chemoradiotherapy With Envafolimab For The Treatment of Locally Advanced Cervical Cancer | not yet recruiting | Phase 2 | 36 | Chongqing University Cancer HospitalOTHER | 1 | Apr 5, 2023 | clinicaltrials |
| NCT05778097 | Adjutant Apalutamide Plus ADT in Post-RP Patients With High Risk of Recurrence (ARES Study)(ARES) | not yet recruiting | Phase 2 | 103 | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical SchoolOTHER | 1 | Mar 21, 2023 | clinicaltrials |
| NCT04999696 | Minimally Invasive Therapy Versus Open Radical Hysterectomy for Management of Early Stage Cervical Cancer(MITOR) | not yet recruiting | N/A | 820 | Chang Gung Memorial HospitalOTHER | 1 | Feb 10, 2023 | clinicaltrials |
| NCT05717582 | Maximal Cytoreductive Therapies on Post-treatment Metastases in Pts With mHSPC During Apalutamide Plus ADT Treatment(CHAMPION) | not yet recruiting | Phase 2 | 47 | Fudan UniversityOTHER | 1 | Feb 8, 2023 | clinicaltrials |
| NCT05210270 | HYpofractionated Pelvic Radiotherapy for Advanced Cervical Cancers INeligible for ChemoTherapy(HYACINCT) | not yet recruiting | Phase 1 / Phase 2 | 55 | University of Santo Tomas Hospital, PhilippinesOTHER | 0 | Jan 31, 2023 | clinicaltrials |
| NCT05681416 | Prostate Cancer Prevention Clinic for Men With Risk of Familial Prostate Cancer(ProFam-Risk) | not yet recruiting | N/A | 300 | Heinrich-Heine University, DuesseldorfOTHER | 0 | Jan 12, 2023 | clinicaltrials |
| NCT05524389 | Study of Early Stage Endometrial Cancer Based on Molecular Classification and Traditional Risk Stratification to Guide Adjuvant Radiotherapy Decisions | not yet recruiting | Phase 3 | 624 | Peking Union Medical College HospitalOTHER | 0 | Nov 23, 2022 | clinicaltrials |
| NCT05614700 | Prostate Reirradiation Toxicity Outcomes Feasibility Study(RO-PIP) | not yet recruiting | N/A | 60 | University of LeedsOTHER | 0 | Nov 15, 2022 | clinicaltrials |
| NCT05373316 | Addition of a Focal Boost in External Beam Radiotherapy for Locally Advanced Prostate Cancer by Online Adaptive MR-guided Radiotherapy(AFFIRM) | not yet recruiting | Phase 2 | 95 | Radboud University Medical CenterOTHER | 1 | Nov 7, 2022 | clinicaltrials |
Data updated 23 days agoSource updated May 16, 2024source: clinicaltrials